Fig. 4
From: Inhibition of monocarboxylate transporter 1 suppresses the proliferation of glioblastoma stem cells
Effects of AR-C117977 on non-CSCs and CSCs. a Cells were treated with AR-C117977 (0.5–25 μM) or 0.2 % DMSO (vehicle) for 72 h (n = 3, mean ± SEM; *p < 0.05, **p < 0.01 vs. non-CSC of each concentration). b The number and size of spheres treated for 6 days with various concentrations of AR-C117977. Scale bars 300 μm. c The intracellular lactate density (nmol/1.0 × 104 cells) of non-CSCs or CSCs treated with AR-C117977 for 72 h (non-CSC) or 6 days (CSC). These data are representative of two independent experiments. CSC cancer stem cell